Laparoscopic Versus Open Left Hemihepatectomy for Liver Benign Lesions
NCT ID: NCT01768728
Last Updated: 2015-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laparoscopic left hemihepatectomy group
Group of patients that are operated with laparoscopic left hemihepatectomy
Laparoscopic left hemihepatectomy
participants will be performed with laparoscopic left hepatectomy using laparoscopic instruments
Open left hemihepatectomy
Group of patients operated with open left hemihepatectomy
Open left hemihepatectomy
participants will be performed with traditional open left hepatectomy using laparotomic instruments
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laparoscopic left hemihepatectomy
participants will be performed with laparoscopic left hepatectomy using laparoscopic instruments
Open left hemihepatectomy
participants will be performed with traditional open left hepatectomy using laparotomic instruments
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Child-Pugh classification of A to B
* American Society Of Anesthesiologists (ASA) grading of I to III
* a body mass index of between 18 and 35
* willingness to participate in the study
* able to understand the nature of the study and what will be required of them
Exclusion Criteria
* unwillingness to participate
* Child-Pugh classification of C
* ASA grading of IV to V
* with condition of acute inflammatory,fever or diabetes mellitus
* with autoimmune disease or immunodeficiency
* taking drugs that affect the immune system
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sir Run Run Shaw Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiujun Cai
Executive Vice-President
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SRRSH20121225-1
Identifier Type: -
Identifier Source: org_study_id